$CPIX
CUMBERLAND PHARMACEUTICALS INC

2021 Q4 Form 10-Q Financial Statement

#000162828021023213 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $8.320M $8.073M $10.26M
YoY Change -18.92% -12.74% 10.27%
Cost Of Revenue $2.225M $1.328M $2.070M
YoY Change 7.5% -38.02% -13.39%
Gross Profit $6.095M $6.745M $8.200M
YoY Change -25.68% -5.11% 18.5%
Gross Profit Margin 73.25% 83.55% 79.91%
Selling, General & Admin $6.719M $5.840M $7.190M
YoY Change -6.56% -2.16% 0.14%
% of Gross Profit 110.24% 86.59% 87.68%
Research & Development $1.613M $1.454M $1.400M
YoY Change 15.2% 18.17% -32.69%
% of Gross Profit 26.46% 21.56% 17.07%
Depreciation & Amortization $1.077M $1.074M $1.230M
YoY Change -12.43% -9.78% 9.82%
% of Gross Profit 17.67% 15.92% 15.0%
Operating Expenses $9.349M $7.294M $9.740M
YoY Change -4.02% 1.31% -5.53%
Operating Profit -$4.354M -$1.563M -$1.746M
YoY Change 149.38% 29.35% -48.56%
Interest Expense -$21.06K $20.02K -$30.00K
YoY Change -29.8% -73.38% -250.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$4.375M -$1.576M -$1.780M
YoY Change 145.79% 23.91% -47.34%
Income Tax $12.52K $7.458K $10.00K
% Of Pretax Income
Net Earnings -$3.848M -$1.055M -$883.8K
YoY Change 335.37% 119.06% -8.01%
Net Earnings / Revenue -46.25% -13.07% -8.61%
Basic Earnings Per Share -$0.26 -$0.07 -$0.06
Diluted Earnings Per Share -$0.26 -$0.07 -$0.06
COMMON SHARES
Basic Shares Outstanding 14.81M shares 14.88M shares 15.04M shares
Diluted Shares Outstanding 14.88M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.04M $25.84M $24.80M
YoY Change 9.04% -2.85% -12.06%
Cash & Equivalents $27.04M $25.84M $24.75M
Short-Term Investments
Other Short-Term Assets $3.340M $1.259M $2.200M
YoY Change 51.82% -29.19% -20.22%
Inventory $8.430M $10.26M $10.64M
Prepaid Expenses
Receivables $6.877M $9.851M $12.38M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $45.69M $47.22M $49.97M
YoY Change -8.57% -3.43% -0.39%
LONG-TERM ASSETS
Property, Plant & Equipment $442.6K $493.5K $574.2K
YoY Change -22.91% -18.15% -23.22%
Goodwill $882.0K $882.0K $882.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.420M $3.302M $3.234M
YoY Change 5.74% 31.45% -1.95%
Total Long-Term Assets $38.77M $40.36M $46.49M
YoY Change -16.61% -14.35% -14.51%
TOTAL ASSETS
Total Short-Term Assets $45.69M $47.22M $49.97M
Total Long-Term Assets $38.77M $40.36M $46.49M
Total Assets $84.46M $87.57M $96.46M
YoY Change -12.44% -8.79% -7.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.641M $9.233M $13.40M
YoY Change -28.03% -14.77% 34.05%
Accrued Expenses $8.668M $1.094M $11.25M
YoY Change -22.98% 9.42% 1.53%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.28M $17.95M $25.67M
YoY Change -24.89% -25.03% 6.28%
LONG-TERM LIABILITIES
Long-Term Debt $15.00M $15.00M $15.00M
YoY Change 0.0% 0.0% -18.92%
Other Long-Term Liabilities $7.489M $7.979M $7.863M
YoY Change -4.76% -13.27% -10.01%
Total Long-Term Liabilities $7.489M $22.98M $7.863M
YoY Change -4.76% -5.05% -10.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.28M $17.95M $25.67M
Total Long-Term Liabilities $7.489M $22.98M $7.863M
Total Liabilities $41.86M $40.92M $49.59M
YoY Change -15.59% -15.03% -7.25%
SHAREHOLDERS EQUITY
Retained Earnings -$5.639M -$1.791M -$2.131M
YoY Change 164.6% 43.59% -276.35%
Common Stock $48.45M $48.61M $49.12M
YoY Change -1.36% -1.15% -1.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $42.81M $46.82M $46.99M
YoY Change
Total Liabilities & Shareholders Equity $84.46M $87.57M $96.46M
YoY Change -12.44% -8.79% -7.73%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$3.848M -$1.055M -$883.8K
YoY Change 335.37% 119.06% -8.01%
Depreciation, Depletion And Amortization $1.077M $1.074M $1.230M
YoY Change -12.43% -9.78% 9.82%
Cash From Operating Activities $1.960M -$102.0K $860.0K
YoY Change 127.87% -111.86% 0.0%
INVESTING ACTIVITIES
Capital Expenditures -$79.36K -$108.3K -$210.0K
YoY Change -62.21% -90.42% -41.67%
Acquisitions
YoY Change
Other Investing Activities $52.57K $0.00 -$100.0K
YoY Change -152.57% -100.0% -104.42%
Cash From Investing Activities -$26.79K -$108.3K -$320.0K
YoY Change -91.63% -83.84% -116.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -735.3K 383.0K -2.430M
YoY Change -69.74% -141.63% 58.82%
NET CHANGE
Cash From Operating Activities 1.960M -102.0K 860.0K
Cash From Investing Activities -26.79K -108.3K -320.0K
Cash From Financing Activities -735.3K 383.0K -2.430M
Net Change In Cash 1.198M 172.8K -1.890M
YoY Change -163.36% -123.67% -252.42%
FREE CASH FLOW
Cash From Operating Activities $1.960M -$102.0K $860.0K
Capital Expenditures -$79.36K -$108.3K -$210.0K
Free Cash Flow $2.039M $6.240K $1.070M
YoY Change 90.56% -99.69% -12.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001087294
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33637
dei Entity Registrant Name
EntityRegistrantName
Cumberland Pharmaceuticals Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TN
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1765329
dei Entity Address Address Line1
EntityAddressAddressLine1
2525 West End Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 950
dei Entity Address City Or Town
EntityAddressCityOrTown
Nashville
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37203
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
255-0068
dei Security12b Title
Security12bTitle
Common stock, no par value
dei Trading Symbol
TradingSymbol
CPIX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14809628 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25843231 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24753796 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9850530 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12377713 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
10262769 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
10638157 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1259098 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2199926 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
47215628 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
49969592 USD
CY2021Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
9476737 USD
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
11656742 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
493488 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
574169 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24918830 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28118316 USD
CY2021Q3 us-gaap Goodwill
Goodwill
882000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
882000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1282275 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2028148 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3301816 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3234338 USD
CY2021Q3 us-gaap Assets
Assets
87570774 USD
CY2020Q4 us-gaap Assets
Assets
96463305 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9233383 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13396286 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1094187 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1016779 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7617913 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11254381 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
17945483 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25667446 USD
CY2021Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
15000000 USD
CY2020Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
15000000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
229605 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1059693 USD
CY2021Q3 cpix Other Long Term Obligations Excluding Current Portion
OtherLongTermObligationsExcludingCurrentPortion
7749421 USD
CY2020Q4 cpix Other Long Term Obligations Excluding Current Portion
OtherLongTermObligationsExcludingCurrentPortion
7862772 USD
CY2021Q3 us-gaap Liabilities
Liabilities
40924509 USD
CY2020Q4 us-gaap Liabilities
Liabilities
49589911 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14850526 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14850526 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14988429 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14988429 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
48612935 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
49121523 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1790903 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2131013 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
46822032 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
46990510 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
-175767 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
-117116 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46646265 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46873394 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87570774 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96463305 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8072540 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9250689 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27665182 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27179600 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1328027 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2142839 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5486005 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6387002 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3800288 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3587842 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11709445 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11160924 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1453873 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1230335 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4071638 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4374392 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2039799 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2381273 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6367438 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6608321 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1013948 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1117086 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3354080 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3284610 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
9635935 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
10459375 USD
us-gaap Costs And Expenses
CostsAndExpenses
30988606 USD
us-gaap Costs And Expenses
CostsAndExpenses
31815249 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1563395 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1208686 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4635649 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3323424 USD
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
7394 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
12004 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
19411 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
70553 USD
CY2021Q3 us-gaap Other Income
OtherIncome
0 USD
CY2020Q3 us-gaap Other Income
OtherIncome
0 USD
us-gaap Other Income
OtherIncome
2187140 USD
us-gaap Other Income
OtherIncome
0 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
20021 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
75210 USD
us-gaap Interest Expense
InterestExpense
70297 USD
us-gaap Interest Expense
InterestExpense
227730 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1576022 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1271892 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1187170 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4792826 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7458 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3728 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22375 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45423 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1583480 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1275620 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1209545 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4838249 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1086693 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-497704 USD
us-gaap Profit Loss
ProfitLoss
281459 USD
us-gaap Profit Loss
ProfitLoss
-2503438 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-31415 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-15967 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-58651 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-47806 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1055278 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-481737 USD
us-gaap Net Income Loss
NetIncomeLoss
340110 USD
us-gaap Net Income Loss
NetIncomeLoss
-2455632 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.10
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.08
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.08
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.31
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.03
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.10
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.15
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2021Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.10
CY2020Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.08
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.08
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.31
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.03
CY2020Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.10
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.15
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14880887 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15134583 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14939919 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15206179 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14880887 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15134583 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15139904 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15206179 shares
us-gaap Profit Loss
ProfitLoss
281459 USD
us-gaap Profit Loss
ProfitLoss
-2503438 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1491004 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
2334811 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1209545 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4838249 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3529245 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3524684 USD
us-gaap Share Based Compensation
ShareBasedCompensation
517081 USD
us-gaap Share Based Compensation
ShareBasedCompensation
805338 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
632646 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
806390 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
33943 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36197 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
2187140 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2527183 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1817490 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2555393 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1696668 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1627350 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1962024 USD
cpix Increase Decrease In Current Operating Liabilities
IncreaseDecreaseInCurrentOperatingLiabilities
-2873596 USD
cpix Increase Decrease In Current Operating Liabilities
IncreaseDecreaseInCurrentOperatingLiabilities
3248450 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-943439 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1585584 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2891759 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2395054 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
1491004 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
2166086 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4382763 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4561140 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
94485 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
95189 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
460888 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
200000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
180613 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1807467 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-475098 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1441768 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
45000000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
44000000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
45000000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
45500000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1792573 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
834014 USD
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0 USD
us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
800000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1025657 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1551463 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2818230 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4685477 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1089435 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1566105 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24753796 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28212635 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25843231 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26646530 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51085253 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
264574 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
441624 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-1065145 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49843058 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
49843058 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
278349 USD
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
769648 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-940589 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48411170 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48411170 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
262415 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
332504 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-497704 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47843377 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46873394 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
162960 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
303088 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
144661 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46877927 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46877927 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
191954 USD
CY2021Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
484965 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
1223491 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47808407 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47808407 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
162167 USD
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
237616 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1086693 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46646265 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates under different assumptions and conditions. The Company's most significant estimates include: (1) its allowances for chargebacks and accruals for rebates and product returns, (2) the allowances for obsolescent or unmarketable inventory and (3) valuation of a contingent consideration liability associated with a business combination.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2021Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1583480 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1275620 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1086693 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-497704 USD
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-31415 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-15967 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1055278 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-481737 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14880887 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15134583 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14880887 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15134583 shares
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1209545 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4838249 USD
us-gaap Profit Loss
ProfitLoss
281459 USD
us-gaap Profit Loss
ProfitLoss
-2503438 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-58651 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-47806 USD
us-gaap Net Income Loss
NetIncomeLoss
340110 USD
us-gaap Net Income Loss
NetIncomeLoss
-2455632 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14939919 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15206179 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
199985 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15139904 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15206179 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
158900 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
197210 shares
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8072540 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9250689 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27665182 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27179600 USD
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
300000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
200000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13782630 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16223162 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16223162 USD
CY2021Q3 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
144583 USD
CY2020Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
128005 USD
CY2020Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
128005 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5812293 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5943732 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5943732 USD
CY2021Q3 us-gaap Inventory Gross
InventoryGross
19739506 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
22294899 USD
CY2021Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
9476737 USD
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
11656742 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
10262769 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
10638157 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0742
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y2M12D
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1282275 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2028148 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1094187 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1016779 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
229605 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1059693 USD
CY2021Q3 cpix Lease Liability
LeaseLiability
1323792 USD
CY2020Q4 cpix Lease Liability
LeaseLiability
2076472 USD
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
100000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
295038 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1019313 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
92478 USD
CY2021Q3 cpix Lessee Operating Lease Liability To Be Paid After Year Three
LesseeOperatingLeaseLiabilityToBePaidAfterYearThree
0 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1406829 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
83037 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1323792 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
910975 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
871441 USD
us-gaap Sublease Income
SubleaseIncome
526868 USD
us-gaap Sublease Income
SubleaseIncome
491391 USD
CY2017Q4 cpix Stock Issued During Period Shelf Registration Proceeds From Saleof Corporate Securities
StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleofCorporateSecurities
100000000 USD
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
44100000 USD
cpix Proceeds From Sale Of Intangible Assets Installment Payment
ProceedsFromSaleOfIntangibleAssetsInstallmentPayment
3000000 USD

Files In Submission

Name View Source Status
0001628280-21-023213-index-headers.html Edgar Link pending
0001628280-21-023213-index.html Edgar Link pending
0001628280-21-023213.txt Edgar Link pending
0001628280-21-023213-xbrl.zip Edgar Link pending
a2021q3-exhibit311.htm Edgar Link pending
a2021q3-exhibit312.htm Edgar Link pending
a2021q3-exhibit321.htm Edgar Link pending
cpix-20210930.htm Edgar Link pending
cpix-20210930.xsd Edgar Link pending
cpix-20210930_cal.xml Edgar Link unprocessable
cpix-20210930_def.xml Edgar Link unprocessable
cpix-20210930_htm.xml Edgar Link completed
cpix-20210930_lab.xml Edgar Link unprocessable
cpix-20210930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pinnaclelocrenewal4thloa.htm Edgar Link pending
pinnaclelocrenewal4thloa001.jpg Edgar Link pending
pinnaclelocrenewal4thloa002.jpg Edgar Link pending
pinnaclelocrenewal4thloa003.jpg Edgar Link pending
pinnaclelocrenewal4thloa004.jpg Edgar Link pending
pinnaclelocrenewal4thloa005.jpg Edgar Link pending
pinnaclelocrenewal4thloa006.jpg Edgar Link pending
pinnaclelocrenewal4thloa007.jpg Edgar Link pending
pinnaclelocrenewal4thloa008.jpg Edgar Link pending
pinnaclelocrenewal4thloa009.jpg Edgar Link pending
pinnaclelocrenewal4thloa010.jpg Edgar Link pending
pinnaclelocrenewal4thloa011.jpg Edgar Link pending
pinnaclelocrenewal4thloa012.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending